Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marjan Sadeghi
Institution:
AbbVie (United States)
Observed institution:
AbbVie (United States)
OpenAlex ID:
A5037428967
Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis
2024
·
Khashayar Dashtipour
, Marjan Sadeghi
, et al.
·
Toxicon
·
4
Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients With Cervical Dystonia in the US
2024
·
Khashayar Dashtipour
, Marjan Sadeghi
, et al.
·
Toxicon
·
1
Treating Upper Limb Spasticity With OnabotulinumtoxinA: Subgroup Analysis of US Practice Patterns From the ASPIRE Study (P12-8.012)
2023
·
Gerard Francisco
, Wayne Feng
, et al.
·
Neurology
Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis (P12-11.005)
2023
·
Khashayar Dashtipour
, Joseph Jankovic
, et al.
·
Neurology
Show more works
View as search
Works count:
4
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
